Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2017 - 2021
Period Ending	Aug '25 Aug 13, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2017 - 2021
Market Capitalization	10,637	11,707	10,437	3,656	3,135	3,752	Upgrade
Market Cap Growth	13.92%	12.17%	185.47%	16.63%	-16.45%	84.00%	Upgrade
Last Close Price	27.04	29.75	33.45	11.72	10.06	12.00	Upgrade
PE Ratio	12.25	17.57	18.05	7.41	8.73	10.09	Upgrade
PS Ratio	1.61	1.86	1.71	0.80	0.72	0.92	Upgrade
PB Ratio	0.76	0.84	1.01	0.38	0.35	0.43	Upgrade
Debt / Equity Ratio	0.30	0.14	0.29	0.51	0.17	0.17	Upgrade
Return on Equity (ROE)	-	5.50%	5.81%	5.30%	4.07%	4.40%	Upgrade
Return on Assets (ROA)	-	0.39%	0.37%	0.34%	0.27%	0.29%	Upgrade
Earnings Yield	8.16%	5.69%	5.54%	13.50%	11.45%	9.91%	Upgrade
FCF Yield	-	-150.39%	-92.30%	-209.94%	-181.29%	-246.49%	Upgrade
Buyback Yield / Dilution	-23.80%	-11.13%	-	0.01%	-0.01%	-	Upgrade

Updated Feb 4, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.